Pharmaceutical Companies which Underreported Prices Paid by Medicaid Reach Settlement with DOJ

Whistleblower, a blog for attorneys, reports that AstraZeneca and Cephalon have both reached settlements with the US Department of Justice totaling $54 million. The companies were accused of deliberately underreporting Average Manufacturer Prices to public health programs. The government accused the companies of underpaying rebates owed to the states that caused the United States to be overcharged for its payments to the states for the Medicaid program.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s